899796-83-9
899796-83-9
Chemical Structure
Milatuzumab
Synonym(s): hLL1; MEDI-115
- CAS No.: 899796-83-9
- Formula:N/A
- Molecular Weight:(145.66 kDa)
IUPAC Name: (S)-2,2-dimethyltetrahydro-2H-pyran-4-amine
SMILES: [Milatuzumab]
Biological Activity: Milatuzumab (hLL1; MEDI-115) is a humanized anti-CD74 monoclonal antibody. CD74, a integral membrane protein, is associated with the promotion of B-cell growth and survival. Milatuzumab causes free radical oxygen generation, and loss of mitochondrial membrane potential. Milatuzumaba also decreases CD20/CD74 aggregates and cell adhesion, to lead to cell death[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Milatuzumab | 99.39% | Milatuzumab (hLL1; MEDI-115) is a humanized anti-CD74 monoclonal antibody. CD74, a integral membrane protein, is associated with the promotion of B-cell growth and survival. Milatuzumab causes free radical oxygen generation, and loss of mitochondrial membrane potential. Milatuzumaba also decreases CD20/CD74 aggregates and cell adhesion, to lead to cell death. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
